z-logo
open-access-imgOpen Access
The importance of intermediate-dose Valacyclovir in primary CMV prophylaxis after Allogeneic-stem cell transplantation, and the advantages of step-wise pre-emptive treatment in CMV reactivation
Author(s) -
Osman Kara,
Sinem Acar,
Tayfun Elibol
Publication year - 2022
Publication title -
medical science and discovery
Language(s) - English
Resource type - Journals
ISSN - 2148-6832
DOI - 10.36472/msd.v9i6.743
Subject(s) - medicine , valganciclovir , ganciclovir , cytomegalovirus , transplantation , cidofovir , foscarnet , autologous stem cell transplantation , gastroenterology , surgery , human cytomegalovirus , immunology , human immunodeficiency virus (hiv) , herpesviridae , virus , viral disease

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here